Published in J Infect Dis on March 15, 2015
Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers | NCT02484417
Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther (2016) 0.86
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev (2017) 0.83
Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts. Viruses (2016) 0.79
Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation. J Control Release (2015) 0.77
Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen. Antiviral Res (2016) 0.75
A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat Cell Biol (2017) 0.75
Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities. Vaccines (Basel) (2017) 0.75
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nat Microbiol (2017) 0.75
CRM1 Inhibitors for Antiviral Therapy. Front Microbiol (2017) 0.75
Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus (RSV) infected infants. Pediatr Res (2017) 0.75
Influence of meteorological conditions on RSV infection in Portugal. Int J Biometeorol (2016) 0.75
Nasosorption is a minimally invasive diagnostic procedure for measurement of viral load and markers of mucosal inflammation in RSV bronchiolitis. J Infect Dis (2017) 0.75
Effect of climate on incidence of respiratory syncytial virus infections in a refugee camp in Kenya: A non-Gaussian time-series analysis. PLoS One (2017) 0.75
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med (2014) 9.74
Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med (2005) 9.47
The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95
Diagnosis and management of bronchiolitis. Pediatrics (2006) 8.11
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet (1999) 7.90
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med (2007) 6.50
Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med (2008) 6.35
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med (2013) 5.06
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet (2001) 4.38
Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med (2004) 4.32
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science (2013) 3.90
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax (2010) 3.84
Primary respiratory syncytial virus infection in mice. J Med Virol (1988) 3.77
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis (2007) 3.62
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis (2008) 3.58
Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med (1988) 3.39
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
In vitro and in vivo activities of anti-influenza virus compound T-705. Antimicrob Agents Chemother (2002) 3.17
Bronchiolitis. Lancet (2006) 3.16
A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med (1991) 3.16
Detection of respiratory viruses by molecular methods. Clin Microbiol Rev (2008) 3.03
Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics (1983) 3.00
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science (2013) 2.95
Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics (1995) 2.87
The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia. Pediatr Infect Dis J (2011) 2.82
Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics (2013) 2.79
Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol (2000) 2.75
Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 2.62
Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr (2003) 2.52
Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res (1985) 2.42
Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr (2007) 2.38
Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J (2003) 2.35
Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br Med J (1978) 2.35
Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA (1985) 2.34
Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis (2013) 2.29
Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis (1998) 2.24
Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study. Pediatrics (2007) 2.23
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Nasal quantity of respiratory syncytical virus correlates with disease severity in hospitalized infants. Pediatr Infect Dis J (2000) 2.22
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol (2001) 2.21
Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc (1992) 2.17
Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis (1995) 2.13
Role of cell culture for virus detection in the age of technology. Clin Microbiol Rev (2007) 2.12
Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med (2014) 2.07
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med (2009) 2.03
High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis (2013) 2.02
Respiratory syncytial virus infections within families. N Engl J Med (1976) 1.99
Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet (2004) 1.98
The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol (2010) 1.97
RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 1.94
A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A (2010) 1.92
Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis (2012) 1.90
Correlation of viral load of respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol (2010) 1.84
Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis (2012) 1.84
Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis (2001) 1.79
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood (2010) 1.77
Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis (2005) 1.74
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis (2005) 1.74
Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis (2007) 1.71
Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med (2011) 1.70
Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am J Respir Crit Care Med (1995) 1.69
Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010. PLoS One (2012) 1.64
Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc (2008) 1.60
Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. J Infect Dis (2013) 1.60
Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis (2011) 1.59
Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant (2013) 1.58
Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol (2011) 1.57
Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A (2008) 1.55
Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol (2005) 1.54
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials. Pediatrics (1997) 1.51
Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc Natl Acad Sci U S A (2013) 1.51
Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis (2010) 1.51
Advances in the laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J (2004) 1.51
Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol (2010) 1.51
Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease. Pediatr Infect Dis J (1987) 1.51
Lack of long-term effects of high-dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis: a randomized placebo-controlled trial. Pediatr Infect Dis J (2014) 1.46
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis (2006) 1.46
Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45
AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther (2006) 1.44
Causal links between RSV infection and asthma: no clear answers to an old question. Am J Respir Crit Care Med (2009) 1.42
Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med (2007) 1.42
Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol (2010) 1.40
Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics (2008) 1.39
Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis (2011) 1.38
Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child (2003) 1.36
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. J Infect Dis (2010) 1.36
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J (2011) 1.34
Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child (2004) 1.34
Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A (2003) 1.33
Association between respiratory syncytial virus hospitalizations in infants and respiratory sequelae: systematic review and meta-analysis. Pediatr Infect Dis J (2013) 1.31
Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev (2008) 1.30
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis (2006) 1.29
Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics (2009) 1.26
A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med (2000) 1.26